Global Oncology Nutrition
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Oncology Nutrition Market Report 2025.
According to cognitive market research-"Global Oncology Nutrition market size 2023 was XX Million. Oncology Nutrition Industry compound annual growth rate (CAGR) will be XX% from 2024 till 2031."
2024 | 2025 | 2032 | 2033 | CAGR | |
---|---|---|---|---|---|
Global Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
Country Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
North Americ Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
Europe Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
Asia Pacific Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
South America Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
Middle East and Africa Market Size | 121212 | 121212 | 121212 | 121212 | 121212 |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Cancer Type |
|
Market Split by Application |
|
Market Split by End-User |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Oncology Nutrition industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Oncology Nutrition Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Oncology nutrition focuses on dietary programs and interventions to support cancer patients experiencing appetite loss, vitamin shortages, and weight shifts. Oncological dietary assistance enhances body function, cancer treatment tolerance, and patient quality of life.Most cancer patients experience malnutrition due to tiredness and physical changes produced by treatment, resulting in weight loss and nutritional deficiencies. Integrating nutritional screening and assessment approaches into cancer care methodology will develop the oncology nutrition sector. Oncology nutrition market trends emphasize the importance of micronutrients in supporting cancer therapy, as well as the use of digital platforms for personalized diets.
The oncology nutrition industry is expanding as cancer rates rise around the world. Dietary supplements used prior to and during cancer treatment provide strength and resilience against treatment-related side effects. The demand for oncology nutrition products in home care settings, as well as enteral nutrition products, is driving growth. The industry is predicted to grow due to the development of elemental formulations and novel non-GMO goods. This expansion is driven by factors such as the transition from parenteral to enteral feeding, rising cancer risk, demand for healthy and nutritional feeding in home healthcare, increased malnutrition therapy, and improved medical research on oncology nutrition.
The World Health Organisation (WHO) ranks cancer as the world's second largest cause of death. According to WHO figures, around 25% of cancer patients die as a result of malnutrition caused by sickness or anticancer medication. In 2020, there were an anticipated 18.1 million cancer cases worldwide. There were 9.3 million male and 8.8 million female cases. In 2020, breast and lung cancers accounted for 12.5% and 12.2% of all new cases diagnosed globally, respectively.
In 2020, there were around 1.9 million new cases of colorectal cancer, accounting for 10.7% of all new cases. Lung cancer was the most common cancer in men globally in 2020, accounting for 15.4% of all new cases. Lung, prostate, and colorectal cancer accounted for 41.9% of all cancers (excluding non-melanoma skin cancer). Stomach and liver cancers each accounted for more than 5%. In 2020, breast cancer accounted for 25.8% of all new cancer cases diagnosed in women globally. Breast, colorectal, and lung cancers made for 44.5% of all cancer cases (excluding non-melanoma skin cancer). Cervical cancer was the fourth most common cancer among women in 2020, accounting for 6.9% of all newly diagnosed cases.
https://www.who.int/news-room/fact-sheets/detail/cancer
Over 1.5 billion individuals will be elderly in the world in 2050, having doubled in the previous three decades. Between 2019 and 2050, the number of elderly people is expected to rise throughout all regions. However, Eastern and Southeast Asia will see the biggest increase.. The World Health Organisation (WHO) projects that by 2050, the proportion of elderly people worldwide will almost double, from 12% to 22%. The market has enormous potential and is very profitable.
Furthermore, the growing older population is predicted to drive the industry's growth in the near future because they are more likely to develop cancer. According to WHO figures, the global population aged 60 and above is expected to exceed 2 billion by 2050. Individuals 65 and older account for almost 60% of all malignancies. Furthermore, this stage accounts for roughly 70% of all cancer-related deaths.
https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text=By%202050%2C%20the%20world's%20population,2050%20to%20reach%20426%20million.
The high cost of oncology nutrition products is a major barrier to growth in the global industry. Cancer patients may require specialised goods with precise nutrient formulations to suit their dietary needs. Specialised goods are more expensive than ordinary nutritional supplements due to increased costs for research, manufacturing, and quality control. Personalised nutrition planning and counselling services increase the expense of oncology nutrition. The high cost of these products may limit their accessibility and affordability, especially for lower-income individuals or patients.
Tube feeding difficulties are projected to slow the oncology nutrition market's development pace. Constipation, dehydration, diarrhoea, skin problems, inadvertent intestine rips, and stomach infection are among potential risks of using a feeding tube. Tube feeding difficulties can have an impact on both the patient's health and the cancer nutrition industry.
The oncology nutrition sector is gaining traction as more private and public organisations focus on raising awareness. The Nutritional Oncology Research Institute (NORI) Nutraceuticals offers high-quality nutritional supplements and specialist nutraceuticals for clinical oncology. NORI combines the power of nutrition with a few extremely natural substances to help halt cancer progression and possibly reverse it.The Academy of Nutrition and Dietetics supports the Oncology Nutrition Dietetic Practice Group through publication and consultancy, which includes advocacy and educational research as an oncology nutrition pioneer with experts.
https://www.oncologynutrition.org/about-us
MNI, the Medical Nutrition International Industry association, represents companies that offer nutritional therapy solutions such as Oral Nutritional Supplements (ONS), Enteral Tube Feeding (enteral nutrition via the gastrointestinal tract), and Parenteral Nutrition (intravenous feeding), as well as other factors operating in the medical nutrition market, such as ingredients and medical devices for nutritional care.
https://www.medicalnutritionindustry.org/
The COVID-19 pandemic focused attention on the oncology nutrition sector, but healthcare systems were significantly impacted. For example, Nutrition and Cancer published a study in May 2021 that aimed to develop nutritional protocols for the management and prevention of problems during the COVID-19 pandemic for all cancer patients. Patients with cancer are more vulnerable to diseases due to either direct immune system damage or anticancer therapy. Furthermore, according to the article published by the National Library of Medicine in June 2021, the role of nutrition, dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 phase, as well as the value of diet in the susceptibility, prevention, and management of COVID-19 in cancer patients.
The COVID-19 epidemic necessitated the creation of nutritional maintenance and complication control guidelines for all cancer patients, according to the same source. However, the market was gradually stabilising as COVID-19 instances decreased, resulting in a restoration to normal demand levels for oncology nutrition. Thus, COVID-19 is likely to have a substantial impact on the cancer nutrition market throughout the forecast period.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872359/
We have various report editions of Oncology Nutrition Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The worldwide Oncology Nutrition market includes both established and new competitors. Market participants prioritize research and development to improve the efficiency and performance of oncology nutrition. Companies often grow their market presence through strategic collaborations, partnerships, and mergers and acquisitions. The competitive environment is influenced by technical breakthroughs, government laws, and the capacity to provide cost-effective and sustainable solutions.
Top Companies Market Share in Oncology Nutrition Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North American area is the largest contributor to the market and is estimated to grow at a CAGR of xx% during the forecast period due to the rising prevalence of cancer in the American region. For example, according to the National Cancer Institute, which is part of the National Institutes of Health (NIH), an estimated 1.8 million new cases of cancer will be identified in the United States in 2020, with 606,520 of them likely to die. As a result of the region's increased cancer risks and incidence, the market for cancer nutrition is in high demand.
Asia-Pacific is likely to experience the fastest growth in the oncology nutrition market during the forecast period, owing to rising nutrition awareness initiatives for cancer patients. The rise in cancer prevalence, combined with the region's growing senior population and high healthcare spending, is one of the driving forces behind the growth of the Asia-Pacific cancer clinical nutrition market.
The current report Scope analyzes Oncology Nutrition Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Oncology Nutrition Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Oncology Nutrition Industry growth. Oncology Nutrition market has been segmented with the help of its Cancer Type, Application End-User, and others. Oncology Nutrition market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The lung cancer segment contributes the most to the market and is predicted to develop at a CAGR of xx% over the forecast period. Nutrition is a significant factor in the progression of lung cancer. According to studies, smokers who consume high quantities of beta-carotene and vitamin A supplements are more likely to develop and die from lung cancer. However, consuming beta-carotene in conjunction with a fruit and vegetable-rich diet can help prevent lung cancer.
According to 2020 data, an estimated 19.3 million cancer cases have been documented worldwide, with a projected increase to 3,096,944 by 2040. Lung cancer is the most common type of tumour, accounting for 2,206,771 new diagnoses worldwide in 2020. The demand for oncology nutrition will increase as the number of people with lung cancer grows, because diet provides the potential to combat illness and resilience against treatment side effects.
https://pubmed.ncbi.nlm.nih.gov/33538338/
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Oncology Nutrition Industry. Request a Free Sample PDF!
Oral nutrition supplements (ons) are the application category's dominant subsegment. Ons are dietary supplements given orally to provide the nutritional requirements of cancer patients. Patients can readily swallow and absorb these products, which are available in liquids, powders, and bars. Oral nutrition supplements are commonly used in oncology care to prevent malnutrition, maintain weight, and improve general nutrition.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Which end-user segment dominated the market in 2023?
Hospitals are the dominant sub-segment in the end-user category. Hospitals play a crucial role in cancer care and treatment, with specialised oncology departments. These facilities offer full care for cancer patients, including nutritional support. Oncology nutrition products are commonly used in hospitals to address malnutrition, enhance healing, and improve patient well-being during cancer treatment.
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
The oncology nutrition sector is expanding as cancer rates rise, as is demand for food goods in home care settings and enteral nutrition products. Factors driving increase include the transition from parenteral to enteral feeding, rising cancer risk, home healthcare demand, malnutrition treatment, and enhanced medical research on oncology nutrition. Innovative non-GMO formulae and elemental formulations are also driving this increase, thus the future for the oncology nutrition market looks bright.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Cancer Type | Brain, Blood, Pancreas, Breast, Neck, Liver, Stomach and Gastrointestinal Cancer |
Application | Oral Nutrition Supplements, Enteral Nutrition |
End-User | Hospitals, Cancer Centers |
List of Competitors | Abbott Laboratories US, Nestle S.A. Switzerland, Danone France, Fresenius Kabi AG Germany, B.Braun Melsungen AG Germany, Mead Johnson Nutrition Company US, Hormel Foods US, Meiji Holdings Japan, Victus US, Global Health Products US |
This chapter will help you gain GLOBAL Market Analysis of Oncology Nutrition. Further deep in this chapter, you will be able to review Global Oncology Nutrition Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Oncology Nutrition. Further deep in this chapter, you will be able to review North America Oncology Nutrition Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Oncology Nutrition. Further deep in this chapter, you will be able to review Europe Oncology Nutrition Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Oncology Nutrition. Further deep in this chapter, you will be able to review Asia Pacific Oncology Nutrition Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Oncology Nutrition. Further deep in this chapter, you will be able to review South America Oncology Nutrition Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East and Africa Market Analysis of Oncology Nutrition. Further deep in this chapter, you will be able to review Middle East and Africa Oncology Nutrition Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Oncology Nutrition. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 7 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 8 Qualitative Analysis (Subject to Data Availability)
Segmentation Cancer Type Analysis 2019 -2031, will provide market size split by Cancer Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 9 Market Split by Cancer Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Application Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-User Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Oncology Nutrition market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Brain have a significant impact on Oncology Nutrition market? |
What are the key factors affecting the Brain and Blood of Oncology Nutrition Market? |
What is the CAGR/Growth Rate of Oral Nutrition Supplements during the forecast period? |
By type, which segment accounted for largest share of the global Oncology Nutrition Market? |
Which region is expected to dominate the global Oncology Nutrition Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|